PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-1.78%
Both yoy net incomes decline, with MCHP at -75.67%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
3.61%
Less D&A growth vs. MCHP's 10.16%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
117.39%
Lower deferred tax growth vs. MCHP's 633.17%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
45.24%
Less SBC growth vs. MCHP's 95.44%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
-174.23%
Both reduce yoy usage, with MCHP at -1561.49%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-161.64%
Both yoy AR lines negative, with MCHP at -423.82%. Martin Whitman would suspect an overall sector lean approach or softer demand.
185.15%
Inventory shrinking or stable vs. MCHP's 663.00%, indicating lean supply management. David Dodd would confirm no demand shortfall.
-415.38%
Negative yoy AP while MCHP is 96.05%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-169.12%
Both reduce yoy usage, with MCHP at -269.58%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
19.05%
Some yoy increase while MCHP is negative at -14.53%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-48.39%
Both yoy CFO lines are negative, with MCHP at -15.89%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
22.29%
Some CapEx rise while MCHP is negative at -53.11%. John Neff would see competitor possibly building capacity while we hold back expansions.
-100.00%
Negative yoy acquisition while MCHP stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
55.26%
Purchases well above MCHP's 34.66%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
-26.77%
We reduce yoy sales while MCHP is 441.34%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
96.62%
We have some outflow growth while MCHP is negative at -51.27%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-22.06%
Both yoy lines negative, with MCHP at -13196.04%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-48.60%
Both yoy lines negative, with MCHP at -3133150.00%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
297.37%
We slightly raise equity while MCHP is negative at -57.86%. John Neff sees competitor possibly preserving share count or buying back shares.
42.66%
Buyback growth of 42.66% while MCHP is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.